- Home
- ASUR vs CRDF Comparison
ASUR vs CRDF Comparison
Compare ASUR & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASUR
- CRDF
- Stock Information
- Founded
- ASUR 1985
- CRDF 1999
- Country
- ASUR United States
- CRDF United States
- Employees
- ASUR N/A
- CRDF N/A
- Industry
- ASUR EDP Services
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASUR Technology
- CRDF Health Care
- Exchange
- ASUR Nasdaq
- CRDF Nasdaq
- Market Cap
- ASUR 297.7M
- CRDF 288.7M
- IPO Year
- ASUR 1992
- CRDF N/A
- Fundamental
- Price
- ASUR $9.80
- CRDF $3.01
- Analyst Decision
- ASUR Strong Buy
- CRDF Strong Buy
- Analyst Count
- ASUR 8
- CRDF 4
- Target Price
- ASUR $13.25
- CRDF $12.00
- AVG Volume (30 Days)
- ASUR 100.8K
- CRDF 1.1M
- Earning Date
- ASUR 03-06-2025
- CRDF 05-01-2025
- Dividend Yield
- ASUR N/A
- CRDF N/A
- EPS Growth
- ASUR N/A
- CRDF N/A
- EPS
- ASUR N/A
- CRDF N/A
- Revenue
- ASUR $119,792,000.00
- CRDF $683,000.00
- Revenue This Year
- ASUR $14.65
- CRDF N/A
- Revenue Next Year
- ASUR $9.05
- CRDF N/A
- P/E Ratio
- ASUR N/A
- CRDF N/A
- Revenue Growth
- ASUR 0.60
- CRDF 39.96
- 52 Week Low
- ASUR $6.89
- CRDF $2.01
- 52 Week High
- ASUR $12.74
- CRDF $6.38
- Technical
- Relative Strength Index (RSI)
- ASUR 45.16
- CRDF 32.05
- Support Level
- ASUR $9.36
- CRDF $3.65
- Resistance Level
- ASUR $9.97
- CRDF $3.88
- Average True Range (ATR)
- ASUR 0.40
- CRDF 0.19
- MACD
- ASUR 0.03
- CRDF -0.08
- Stochastic Oscillator
- ASUR 44.78
- CRDF 5.79
About ASUR Asure Software Inc
Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) solutions delivered as Software-as-a-Service (SaaS). It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its HCM products majorly in the United States.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").